It is characterized by impaired cholinergic function in the brain, and donepezil has been used in the treatment of AD as a cholinergic enhancer to inhibit acetylcholinesterase (AChE), resulting in increased acetylcholine levels in synaptic clefts. The gene discussed is ACHE; the disease is Alzheimer disease.